DECOY THERAPEUTICS
Decoy Therapeutics is a preclinical stage biotech company building a pandemic preparedness drug development platform using AI design of peptide ‘decoys’ that directly interfere with viral replication machinery.
DECOY THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2020-01-01
Status:
Active
Total Funding:
250 K USD
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Rain Therapeutics
Rain Therapeutics is a operator of a clinical stage biotechnology company.
Current Employees Featured
Rick Pierce
Rick Pierce CEO @ Decoy Therapeutics CEO
Founder
Barb Hibner
Rick Pierce
Investors List
Massachusetts Life Sciences Center
Massachusetts Life Sciences Center investment in Convertible Note - Decoy Therapeutics